Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Enhanced early T cell activation and protection from hyper-inflammation in smoke exposed Cox4i2−/− infected mice with influenza

T Berger, C F Garcia Castro, V Lakshmi, S Völkel, N Sommer, C Skevaki
European Respiratory Journal 2022 60: 4483; DOI: 10.1183/13993003.congress-2022.4483
T Berger
1Institute of Laboratory Medicine and Pathobiochemistry, Marburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C F Garcia Castro
2Department of Internal Medicine, Gießen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V Lakshmi
2Department of Internal Medicine, Gießen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S Völkel
1Institute of Laboratory Medicine and Pathobiochemistry, Marburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N Sommer
2Department of Internal Medicine, Gießen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C Skevaki
1Institute of Laboratory Medicine and Pathobiochemistry, Marburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Respiratory virus infections are a major cause of concern in chronic obstructive pulmonary disease (COPD). Mitochondrial reactive oxygen species (mtROS) play an important role in immune function and increased mtROS levels may have an effect in COPD. Cox4i2 regulates ROS production at complex III and has been shown implicated in the development of emphysema.

We hypothesize that Cox4i2−/− mice are protected from smoke-induced hyper-inflammation but also exhibit impaired T cell activation and antiviral immunity.

We analyzed T cell subsets, BAL Albumin leakage and virus load via qPCR. C57BL/6 (WT) and Cox4i2−/− mice were exposed for two weeks to smoke (CS) or room air (RA), with or without H1N1 influenza A/Puerto Rico/8/1934 (PR8) infection. Mice were sacrificed 3 and 10 days post infection (DPI).

There was no difference in viral load at 3 DPI, but at 10 DPI WT CS mice showed higher virus load when compared to WT RA mice. Infection led to increased albumin leakage in all groups but not Cox4i2−/− CS mice. CD69 on CD4+ T cells increased after infection, particularly in CS Cox4i2−/− mice vs. both WT groups at 3 DPI. In CD8+ T cells Cox4i2−/− CS mice showed similar CD69 upregulation as WT RA mice. Intracellular staining of IFN-γ in CD8+ T Cells was lower in both Cox4i2−/− groups at 10 DPI. Restimulation with virus peptide showed impaired IFN-γ production in both Cox4i2−/− groups and WT CS mice at 10 DPI.

Taken together Cox4i2−/− did not show impaired T cell activation albeit decreased albumin leakage and IFN-γ production at 10 DPI indicate a protection effect over hyper-inflammation, especially in Cox4i2−/− CS mice.

  • COPD
  • Immunology
  • Viruses

Footnotes

Cite this article as Eur Respir J 2022; 60: Suppl. 66, 4483.

This article was presented at the 2022 ERS International Congress, in session “-”.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2022
Previous
Back to top
Vol 60 Issue suppl 66 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Enhanced early T cell activation and protection from hyper-inflammation in smoke exposed Cox4i2−/− infected mice with influenza
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Enhanced early T cell activation and protection from hyper-inflammation in smoke exposed Cox4i2−/− infected mice with influenza
T Berger, C F Garcia Castro, V Lakshmi, S Völkel, N Sommer, C Skevaki
European Respiratory Journal Sep 2022, 60 (suppl 66) 4483; DOI: 10.1183/13993003.congress-2022.4483

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Enhanced early T cell activation and protection from hyper-inflammation in smoke exposed Cox4i2−/− infected mice with influenza
T Berger, C F Garcia Castro, V Lakshmi, S Völkel, N Sommer, C Skevaki
European Respiratory Journal Sep 2022, 60 (suppl 66) 4483; DOI: 10.1183/13993003.congress-2022.4483
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Late Breaking Abstract - DESTINATION: tezepelumab long-term safety and efficacy versus placebo in patients with severe, uncontrolled asthma
  • Innate immunity plays an important role during NTHI and RV sequential infection
  • Assessment of sputum inflammatory, neural, and remodelling mediators in eosinophilic and non-eosinophilic asthma
Show more 05.03 - Allergy and immunology

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society